Global Paroxetine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Paroxetine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Paroxetine is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is used to treat major depressive disorder, obsessive-compulsive disorder, social anxiety disorder, panic disorder, posttraumatic stress disorder, generalized anxiety disorder and premenstrual dysphoric disorder. It has also been used in the treatment of hot flashes and night sweats associated with menopause.
Paroxetine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Paroxetine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Depression and Panic disorder are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Paroxetine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Paroxetine key manufacturers include Apotex, Sebela Pharmaceuticals, Teva, Mylan, Sun Pharmaceutical, Lupin, Lannett Company, Aurobindo and Jubilant Pharma, etc. Apotex, Sebela Pharmaceuticals, Teva are top 3 players and held % sales share in total in 2022.
Paroxetine can be divided into Paroxetine Hydrochloride Drug and Paroxetine Mesylate Drug, etc. Paroxetine Hydrochloride Drug is the mainstream product in the market, accounting for % sales share globally in 2022.
Paroxetine is widely used in various fields, such as Depression, Panic disorder, Social anxiety disorder and Others, etc. Depression provides greatest supports to the Paroxetine industry development. In 2022, global % sales of Paroxetine went into Depression filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Paroxetine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Apotex
Sebela Pharmaceuticals
Teva
Mylan
Sun Pharmaceutical
Lupin
Lannett Company
Aurobindo
Jubilant Pharma
Sciecure Pharma
Segment by Type
Paroxetine Hydrochloride Drug
Paroxetine Mesylate Drug
Depression
Panic disorder
Social anxiety disorder
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Paroxetine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Paroxetine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Paroxetine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Paroxetine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Paroxetine introduction, etc. Paroxetine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Paroxetine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Paroxetine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Paroxetine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Depression and Panic disorder are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Paroxetine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Paroxetine key manufacturers include Apotex, Sebela Pharmaceuticals, Teva, Mylan, Sun Pharmaceutical, Lupin, Lannett Company, Aurobindo and Jubilant Pharma, etc. Apotex, Sebela Pharmaceuticals, Teva are top 3 players and held % sales share in total in 2022.
Paroxetine can be divided into Paroxetine Hydrochloride Drug and Paroxetine Mesylate Drug, etc. Paroxetine Hydrochloride Drug is the mainstream product in the market, accounting for % sales share globally in 2022.
Paroxetine is widely used in various fields, such as Depression, Panic disorder, Social anxiety disorder and Others, etc. Depression provides greatest supports to the Paroxetine industry development. In 2022, global % sales of Paroxetine went into Depression filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Paroxetine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Apotex
Sebela Pharmaceuticals
Teva
Mylan
Sun Pharmaceutical
Lupin
Lannett Company
Aurobindo
Jubilant Pharma
Sciecure Pharma
Segment by Type
Paroxetine Hydrochloride Drug
Paroxetine Mesylate Drug
Segment by Application
Depression
Panic disorder
Social anxiety disorder
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Paroxetine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Paroxetine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Paroxetine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Paroxetine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Paroxetine introduction, etc. Paroxetine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Paroxetine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices